Aller au contenu principal
Profil bibliographique

Haris Mumtaz Malik

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

29Publications signalées
15Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Glioma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersBrain Metastases and TreatmentLymphoma Diagnosis and TreatmentPancreatic and Hepatic Oncology Research

Les publications récentes

Accès ouvert 2026 conference-abstract OpenAlex

Stereotactic body radiotherapy versus non-SBRT radiotherapy for medically inoperable stage I non–small cell lung cancer in elderly patients: A systematic review and meta-analysis.

FNU Sawaira, Aizaz Anwar Khalid, Owais Gul, Muhammad Waqas et autres

e20038 Background: Elderly patients with medically inoperable stage I non–small cell lung cancer (NSCLC) are commonly treated with radiation therapy. While stereotactic body radiotherapy (SBRT) is widely used, its benefits compared with conventional and hypofractionated radiotherapy in this population remain debated. We …

pk, us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 review OpenAlex

Early versus delayed laparoscopic appendectomy for acute uncomplicated appendicitis in adults: a systematic review and meta-analysis

Iftikhar Hussain Khan, Soban Ali Qasim, Haris Mumtaz Malik, Muhammad Hamza et autres

BACKGROUND: The optimal timing of laparoscopic appendectomy for acute uncomplicated appendicitis remains uncertain. We performed a systematic review and meta-analysis to compare operative and safety outcomes following early versus delayed laparoscopic appendectomy in adults. METHODS: PubMed, Cochrane Central, and ClinicalTrials.gov were searched …

pk, af, us (code pays fourni par la source)

2 citations BMC Surgery
Accès ouvert 2025 review OpenAlex

Efficacy and safety of dapsone in adult immune thrombocytopenia: a systematic review and meta-analysis

Iftikhar Mohammad Khan, Soban Ali Qasim, Shree Rath, Haris Mumtaz Malik et autres

BACKGROUND: Immune thrombocytopenia (ITP) is an autoimmune condition often managed with corticosteroids, intravenous immunoglobulins, or thrombopoietin receptor agonists. In settings where these therapies are inaccessible or contraindicated, dapsone an older antimicrobial agent with immunomodulatory effects has been proposed as an alternative, though …

pk, in, jo, af (code pays fourni par la source)

1 citation European journal of medical research
2025 conference-abstract OpenAlex

S316 Efficacy and Safety of Sintilimab (PD-1 Inhibitor) Combined With Anti-VEGF Therapy as Neoadjuvant Treatment in Colorectal Cancer: A Systematic Review and Proportional Meta-Analysis

Haris Mumtaz Malik, Beenish Sabir, Adnan Bhat, Waseem Nabi et autres

Introduction: Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the gold-standard surgical treatment for ulcerative colitis and familial adenomatous polyposis. While IPAA preserves continence and avoids a permanent stoma, it carries risks such as pouchitis and pouch failure. Pelvic radiation, used for …

0 citations The American Journal of Gastroenterology
2025 conference-abstract OpenAlex

S1059 Efficacy and Safety of Tislelizumab in Esophageal Squamous Cell Carcinoma: A Proportionality Meta-Analysis

Haris Mumtaz Malik, Arun Kumar Maloth, Adnan Bhat, Muhammad Ansab et autres

Introduction: Tislelizumab, a humanized anti–programmed cell death protein 1 monoclonal antibody, has shown promising antitumor activity in esophageal squamous cell carcinoma (ESCC), a malignancy with poor prognosis and limited therapeutic options. While individual studies report variable outcomes, a comprehensive meta-analysis quantifying its …

0 citations The American Journal of Gastroenterology
2025 article OpenAlex

Efficacy of neoadjuvant combination immune checkpoint inhibitor therapy in patients with resectable high grade melanomas: A systematic review and meta analysis of randomised control trials.

Shariq Ahmad Wani, Mir Wajid Majeed, Paweł Marek Łajczak, Ayesha Ayesha et autres

e21512 Background: The standard treatment for resectable, macroscopic stage 3 melanoma is Surgery followed by adjuvant therapy but neoadjuvant combination immune checkpoint inhibitor(ICI) therapy has shown to significantly increase the survival of patients. This proportional systematic review and metaanalysis aims to evaluate …

in, pl, pk, us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Comparative safety and efficacy of tislelizumab with or without chemotherapy versus chemotherapy alone in patients with lung cancer: A systematic review and meta-analysis.

Aman Ullah, Faseeh Haider, Adnan Bhat, Vatsal Makhija et autres

e20593 Background: Tislelizumab, an anti-PD-1 antibody, is emerging as a promising immunotherapy agent and has demonstrated clinical benefit and acceptable tolerability in recent lung cancer trials. This study aims to assess the safety and efficacy of Tislelizumab, as monotherapy or combined with …

us, pk, in (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 conference-abstract OpenAlex

Busulfan and cyclophosphamide vs busulfan and fludarabine for myeloablation in the patients of acute myeloid leukaemia/ myelodysplastic syndrome undergoing stem cell transplant: A systematic review and meta-analysis.

Haris Mumtaz Malik, Ramzan Hassan Farooq, Faraz Ali, Beenish Sabir et autres

e18545 Background: Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are key indications for hematopoietic stem cell transplantation (HSCT). While the Busulfan-Cyclophosphamide (BuCy) regimen has been a standard, it carries high risks of hepatic veno-occlusive disease (HVOD) and non-relapse mortality (NRM), especially …

pk, us, qa (code pays fourni par la source)

0 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.